Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PostbiotiX Restore is an oral food supplement developed by Postbiotica, an innovative biotechnology company specializing in microbiota research. The product is formulated using the proprietary PBTech® technology, which involves a natural fermentation process of fructooligosaccharides (FOS) by the strain *Lactobacillus paracasei* CNCM I-5220. This process produces a postbiotic complex intended to support the rebalancing of the intestinal microbiota and restore the function of the intestinal mucosal barrier. PostbiotiX Restore is designed to counteract inflammatory processes and regulate intestinal well-being in patients with various intestinal disorders. It is gluten-free and lactose-free, making it suitable for individuals with food intolerances, and was developed in partnership with Kalichem and SMARTFARMA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PostbiotiX Restore.